Literature DB >> 17174586

Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France.

Noémie Assous1, Emmanuel Touzé, Christophe Meune, André Kahan, Yannick Allanore.   

Abstract

INTRODUCTION: Rheumatoid arthritis (RA) was independently associated with cardiovascular events in several studies, most of which were conducted in the US.
OBJECTIVES: To estimate the risk of cardiovascular events in a cohort of RA patients recruited at a hospital in France, to identify cardiovascular risk factors, and to measure the severity of cardiovascular events.
METHODS: Two hundred and thirty-nine patients admitted between January 1, 1998, and March 31, 1999, for RA meeting American College of Rheumatology criteria, with a negative history for cardiovascular events, were sent a questionnaire in 2004 to evaluate the occurrence of myocardial infarction, stroke, or cardiovascular death.
RESULTS: During the mean follow-up of 5.4+/-1.8 years, there were 10 cases of myocardial infarction (0.8%/year), 3 cases of stroke (0.2%/year), and 9 cardiovascular deaths (0.7%/year). Of the 10 patients who experienced myocardial infarction, 5 had clinical symptoms of heart failure and 4 died from cardiovascular causes. Independent risk factors for cardiovascular events were older age (relative risk [RR], 2.5/10 years; 95% confidence interval [95%CI], 1.4-4.2), male gender (RR, 5.1; 95%CI, 1.8-14.6), treated hypertension (RR, 4.3; 95%CI, 1.4-13.2), and treated hypercholesterolemia (RR, 6.0; 95%CI, 1.8-20.7).
CONCLUSION: Our data suggest a higher risk of cardiovascular events in patients with RA compared to the general population in France (0.1-0.5%/year for myocardial infarction and 0.07%/year for stroke in the age group covered by our cohort). Cardiovascular events in the patients with RA seemed unusually severe. Patients with RA should be carefully screened for conventional cardiovascular risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 17174586     DOI: 10.1016/j.jbspin.2006.10.001

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  11 in total

1.  A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis.

Authors:  Rachana Mishra; Aastha Singh; Vishal Chandra; Mahendra P S Negi; Baishnab C Tripathy; Jaya Prakash; Varsha Gupta
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

Review 2.  Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases.

Authors:  Elena Bartoloni; Alessia Alunno; Roberto Gerli
Journal:  Nat Rev Cardiol       Date:  2017-08-24       Impact factor: 32.419

3.  Is hypertension associated with arthritis? The United States national health and nutrition examination survey 1999-2018.

Authors:  Xiaopeng Liang; Oscar Hou In Chou; Ching Lung Cheung; Bernard M Y Cheung
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

4.  C-reactive protein is linked to lower cognitive performance in overweight and obese women.

Authors:  V Sweat; V Starr; H Bruehl; A Arentoft; A Tirsi; E Javier; A Convit
Journal:  Inflammation       Date:  2008-03-18       Impact factor: 4.092

5.  Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis.

Authors:  Daniel Carranza-Leon; Rany Octaria; Michelle J Ormseth; Annette Oeser; Joseph F Solus; Yahua Zhang; Chimalum R Okafor; Jens Titze; C Michael Stein; Cecilia P Chung
Journal:  Clin Rheumatol       Date:  2017-12-14       Impact factor: 2.980

Review 6.  The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Leena R Baghdadi; Richard J Woodman; E Michael Shanahan; Arduino A Mangoni
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

7.  Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  K Visser; W Katchamart; E Loza; J A Martinez-Lopez; C Salliot; J Trudeau; C Bombardier; L Carmona; D van der Heijde; J W J Bijlsma; D T Boumpas; H Canhao; C J Edwards; V Hamuryudan; T K Kvien; B F Leeb; E M Martín-Mola; H Mielants; U Müller-Ladner; G Murphy; M Østergaard; I A Pereira; C Ramos-Remus; G Valentini; J Zochling; M Dougados
Journal:  Ann Rheum Dis       Date:  2008-11-25       Impact factor: 19.103

Review 8.  The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Louise E Full; Cristina Ruisanchez; Claudia Monaco
Journal:  Arthritis Res Ther       Date:  2009-04-03       Impact factor: 5.156

Review 9.  Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature.

Authors:  Inger L Meek; Harald E Vonkeman; Mart A F J van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2014-04-29       Impact factor: 2.362

Review 10.  Established and Emerging Mechanisms in the Pathogenesis of Arrhythmogenic Cardiomyopathy: A Multifaceted Disease.

Authors:  Shanshan Gao; Deepa Puthenvedu; Raffaella Lombardi; Suet Nee Chen
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.